# A 6-month Randomised, Double-blind, Open Arm Comparator, Phase IIb, With AZD9056, in Patients With Rheumatoid Arthritis (RA)

> **NCT00520572** · PHASE2 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 385 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** AZD9056
- **DRUG:** Etanercept
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00520572
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-08
- **Primary completion:** —
- **Final completion:** 2009-03
- **Target enrollment:** 385 (ACTUAL)
- **Last updated:** 2013-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00520572

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00520572, "A 6-month Randomised, Double-blind, Open Arm Comparator, Phase IIb, With AZD9056, in Patients With Rheumatoid Arthritis (RA)". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT00520572. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*